Dynamics of Inflammatory Mediators in Patients with the Neuroischemic Form of Diabetic Foot Syndrome

Possibilities of using a drug with a multifactorial mechanism of action in the treatment of patients with ischemic heart disease with rhythm disturbances and diabetes mellitus

The effect of melatonin deficiency on the carbohydrate metabolism in patients with type 2 diabetes mellitus

ESC guidelines, chronic coronary syndrome, ranolazine, diabetes mellitus, insulin resistance

Substantiation of the effectiveness of enterosorption in patients with neuroischemic forms of diabetic foot syndrome

Study of the role of proinflammatory cytokines in the progression of diabetic nephropathy

Metformin is a first-line antihyperglycemic drug: from mechanisms of action to NICE guidelines